Milestone Pharmaceuticals
MIST
MIST
40 hedge funds and large institutions have $39.9M invested in Milestone Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less capital invested
Capital invested by funds: $56.4M → $39.9M (-$16.5M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
40
Holding in Top 10
1
Calls
$44K
Puts
$27K
Top Buyers
| 1 | +$656K | |
| 2 | +$379K | |
| 3 | +$72.7K | |
| 4 |
LPC
Lion Point Capital
New York
|
+$52.8K |
| 5 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$36.9K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$895K | |
| 3 | -$787K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$294K |
| 5 |
ACM
Altium Capital Management
New York
|
-$265K |